首页> 外文期刊>Stem Cell Research & Therapy >Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells
【24h】

Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells

机译:月经干细胞的表征:与骨髓间充质干细胞相比,血管生成作用,迁移和造血干细胞支持

获取原文
           

摘要

Stem cells isolated from menstrual fluid (MenSCs) exhibit mesenchymal stem cell (MSCs)-like properties including multi-lineage differentiation capacity. Besides, menstrual fluid has important advantages over other sources for the isolation of MSCs, including ease of access and repeated sampling in a noninvasive manner. Such attributes allow the rapid culture of MenSCs in numbers that are sufficient for therapeutical doses, at lower cell passages. In this study, we advance the characterization of MenSC populations in comparison to bone marrow derived mesenchymal stem cells (BM-MSCs) with regards to proliferation, lineage differentiation, migration potential, secretion profile and angiogenic properties in vitro and in a matrigel plug assay in mice. We additionally tested their ability to support hematopoietic stem cell (HSC) expansion in vitro. The phenotypic analysis of MenSCs revealed a profile largely similar to the BM-MSCs with the exception of a higher expression of the adhesion molecule CD49a (alpha1-integrin). Furthermore, the fibroblast colony forming units (CFU-F) from MenSCs yielded a 2 to 4 fold higher frequency of progenitors and their in vitro migration capacity was superior to BM-MSCs. In addition, MenSCs evidenced a superior paracrine response to hypoxic conditions as evidenced by the secretion of vascular endothelial growth factor and basic fibroblast growth factor and also improved angiogenic effect of conditioned media on endothelial cells. Furthermore, MenSCs were able to induce angiogenesis in a matrigel plug assay in vivo. Thus, an 8-fold increase in hemoglobin content was observed in implanted plugs containing MenSCs compared to BM-MSCs. Finally, we demonstrated, for the first time, the capacity of MenSCs to support the ex-vivo expansion of HSCs, since higher expansion rates of the CD34?+?CD133+ population as well as higher numbers of early progenitor (CFU-GEMM) colonies were observed in comparison to the BM source. We present evidence showing superiority of MenSCs with respect to several functional aspects, in comparison with BM-MSCs. However, the impact of such properties in their use as adult-derived stem cells for regenerative3 medicine remains to be clarified.
机译:从月经液(MenSCs)分离出的干细胞表现出间充质干细胞(MSCs)样的特性,包括多系分化能力。此外,月经液相对于其他来源的MSC分离具有重要优势,包括易于进入和以无创方式进行重复采样。这些属性允许在较低的细胞传代中以足以治疗剂量的数量快速培养MenSC。在这项研究中,我们在体外和基质胶塞测定中,与骨髓衍生的间充质干细胞(BM-MSC)相比,在增殖,谱系分化,迁移潜力,分泌概况和血管生成特性方面进行了MenSC群体的表征。老鼠。我们还测试了它们在体外支持造血干细胞(HSC)扩增的能力。 MenSCs的表型分析显示,除了粘附分子CD49a(α1-integrin)的表达较高外,其与BM-MSCs的概况非常相似。此外,来自MenSC的成纤维细胞集落形成单位(CFU-F)产生的祖细胞频率高2至4倍,其体外迁移能力优于BM-MSC。此外,MenSCs表现出对低氧条件的优异旁分泌反应,如血管内皮生长因子和碱性成纤维细胞生长因子的分泌所证明的,并且还改善了条件培养基对内皮细胞的血管生成作用。此外,MenSCs能够在体内的基质胶栓试验中诱导血管生成。因此,与BM-MSC相比,在含有MenSCs的植入栓塞中观察到血红蛋白含量增加了8倍。最后,我们首次证明了MenSC支持HSC体外扩增的能力,因为CD34?+?CD133 +群体的扩增率更高,早期祖细胞(CFU-GEMM)菌落的数量也更高与BM来源相比,观察到了。我们提供的证据显示,与BM-MSC相比,MenSCs在几个功能方面具有优越性。但是,这些性质在用作成人来源干细胞用于再生医学中的影响尚待弄清。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号